Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts

European Respiratory Journal

Volumn 32, Issue 3, 2008, Pages 555-562

  Haag, S ^a   Matthiesen, S ^a   Juergens, U R ^a   Racke K ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Airway remodelling; Collagen synthesis; Lung fibroblasts; Mitogen activated protein kinase; Muscarinic receptors; Tiotropium

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CARBACHOL; CELL PROTEIN; COLLAGEN; COLLAGENASE; MUSCARINIC RECEPTOR; OXOTREMORINE; PROLINE; TIOTROPIUM BROMIDE; TRANSFORMING GROWTH FACTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; COLLAGEN SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PERTUSSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STIMULATION; CELL LINE; CYTOLOGY; FIBROBLAST; LUNG; METABOLISM; PHYSIOLOGY;

CELL LINE; CHOLINERGIC ANTAGONISTS; COLLAGEN; FIBROBLASTS; HUMANS; LUNG; RECEPTORS, MUSCARINIC;

EID: 58149376396     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00129307     Document Type: Article

References (29)

1. Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1: 176-183.
2. Molfino NA, Jeffery PK. Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies. Pulm Pharmacol Ther 2007; 20: 462-472.
3. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653.
4. Barnes PJ. The role of anticholinergics in chronic obstructive pulmonary disease. Am J Med 2004; 20: Suppl. 17, 24S-32S.
5. Vincken W, van Noord JA, Greefhorst AP, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Resp J 2002; 19: 209-216.
6. Anzueto A, Tashkin D, Menjoge S, Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther 2005; 18: 75-81.
7. Racké K, Matthiesen S. The airway cholinergic system: physiology and pharmacology. Pulm Pharmacol Ther 2004; 17: 181-198.
8. Racké K, Juergens UR, Matthiesen S. Control by cholinergic mechanisms. Eur J Pharmacol 2006; 533: 57-68.
9. Krymskaya VP, Orsini MJ, Eszterhas AJ, et al. Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. J Respir Cell Mol Biol 2000; 23: 546-554.
10. Gosens R, Nelemans SA, Grootte Bromhaar MM, McKay S, Zaagsma J, Meurs H. Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. J Respir Cell Mol Biol 2003; 28: 257-262.
11. Gosens R, Bos IS, Zaagsma J, Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 2005; 171: 1096-1102.
12. Bos IS, Gosens R, Zuidhof AB, et al. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 2007; 30: 653-661.
13. Jacobs JP, Jones CM, Baille JP. Characteristics of a human diploid cell designated MRC-5. Nature 1970; 227: 168-170.
14. Matthiesen S, Bahulayan A, Kempkens S, et al. Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. Am J Respir Cell Mol Biol 2006; 35: 621-627.
15. Matthiesen S, Bahulayan A, Racké K. MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation. Life Sci 2007; 80: 2259-2262.
16. Peterkofsky B, Diegelmann R. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1997; 10: 988-994.
17. Schaeffer MR, Efron PA, Thornton FJ, Klingel K, Gross SS, Barbul A. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997; 158: 2375-2381.
18. Trevisan R, Yip J, Sarika L, Li LK, Viberti G. Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. J Am Soc Nephrol 1997; 8: 1133-1139.
19. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997; 99: 1313-1321.
20. 1-induced extracellular matrix deposition by primary human lung fibroblasts. J Cell Physiol 2007; 210: 167-176.
21. André C, Marullo S, Convents A, et al. A human embryonic lung fibroblast with a high density of muscarinic acetylcholine receptors. Eur J Biochem 1988; 171: 401-177.
22. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Nat Acad Sci USA 1995; 92: 7686-7689.
23. Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide. Life Sci 2007; 80: 2270-2273.
24. Bühling F, Lieder N, Kühlmann UC, Waldburg N, Welte T. Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med 2007; 101: 2386-2394.
25. Huang S, Wettlaufer SH, Hogaboam C, Aronoff DM, Peters-Golden M. Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol 2007; 292: L405-L413.
26. Caulfield MP, Birdsall NJM. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998; 50: 279-290.
27. Disse B, Reichl R, Speck G, Traunecker W, Rominger KL, Hammer R. Ba 679 BR, a novel long-acting anticholinergic bronchodilator. Life Sci 1963; 52: 537-544.
28. Disse B, Speck GA, Rominger KL, Witek TJ Jr, Hammer R. Tiotropium (Spiriva™): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 1999; 64: 457-464.
29. Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signalling in the pathophysiology of asthma and COPD. Respir Res 2006; 7: 73.